Results 201 to 210 of about 50,545 (304)

Identification and Structural Elucidation of a New Synthetic Cannabinoid, MDMB‐5′Br‐PINACA, in Seized Herbal Materials

Drug Testing and Analysis, Volume 18, Issue 3, Page 334-340, March 2026.
MDMB‐5Br‐PINACA, a novel synthetic cannabinoid, was identified and structurally characterized in seized herbal products using GC‐MS, LC‐HRMS, and NMR. The discovery underscores ongoing diversification of SCs and the need for vigilant surveillance.
Alexandre Barcia de Godoi, Lucas André Zeoly, Rafael Lanaro, Ingrid Simões Oliveira, Mariana Cepollaro Diana, Mauricio Yonamine, Jose Luiz Costa   +6 more
wiley   +1 more source

Modulatory Effects of "Minor" Cannabinoids in an in vitro Model of Neuronal Hypersensitivity. [PDF]

J Pain Res
Anand U, Anand P, Sodergren MH.
europepmc   +1 more source

Differential Alterations in Offset Analgesia and Conditioned Pain Modulation in Fibromyalgia: Evidence for Distinct Central Dysregulation

European Journal of Pain, Volume 30, Issue 3, March 2026.
ABSTRACT Background Chronic pain often involves abnormalities in central pain processing. Two commonly used experimental methods for central pain modulation are conditioned pain modulation (CPM) and offset analgesia (OA). However, it is uncertain how similar the underlying processes they measure are.
Yara Agbaria, Giris Jacob, Raz Preger, Jacob N. Ablin, Valerie Aloush, Haggai Sharon   +5 more
wiley   +1 more source

Antiseizure Effects of Cannabidiol in Combination With Cannabigerol in the Maximal Electroshock Seizure Model. [PDF]

Basic Clin Pharmacol Toxicol
Zhou HZ, Scott BW, Oleksak YI, Burnham WM.   +3 more
europepmc   +1 more source

Prescription Trends and Clinical Decision‐Making in Neuropathic Pain Pharmacological Treatment: Results From a Cross‐Sectional Survey by the Spanish Pain Society

European Journal of Pain, Volume 30, Issue 3, March 2026.
ABSTRACT Background Neuropathic pain (NP) is a complex chronic condition with limited therapeutic effectiveness. Despite multiple drug classes and international guidelines, real‐world adherence remains inconsistent, and data on prescribing practices among pain specialists is scarce. Methods We conducted a nationwide cross‐sectional survey among members
Miguel Á. Huerta, Mónica Mayo‐Moldes, Miguel M. Garcia, Beliu García‐Parra, Mercè Matute, Yolanda López‐Tofiño, Nancy Paniagua, Mar Hernández‐Secorún, Dolors Soler, Marcos Salmerón, Julian Taylor, Enrique Verdú, José A. Valencia, Silvia Pico, Clara Díaz‐Alejo, Masahito Katsuki, Ancor Serrano‐Afonso, M. Carmen Ruiz‐Cantero   +17 more
wiley   +1 more source

Proceedings of the 2025 Cannabis Clinical Outcomes Research Conference. [PDF]

Med Cannabis Cannabinoids
Goodin AJ, Jyot J, Cook RL, Wang Y, Lopez-Quintero C, Hasan M, Winterstein AG.   +6 more
europepmc   +1 more source

Molecular Pharming: Advances, Applications, and Future Prospects in Biotechnology and Medicine

Engineering in Life Sciences, Volume 26, Issue 3, March 2026.
ABSTRACT Genetically engineered plants incorporate the use of a novel bioreactor known as molecular pharming, which has a transformative view on the pharmaceutical industry. The technique enables mass production, at a low cost, and reproducibly of a large number of different protein‐based drugs, vaccines, and industrial enzymes. This review‐based study
Md. Hridoy Ahmed, Md. Mustak Khan, Shishir Dutta, Md. Foyzur Rahman, Mohammad Shariful Islam, Md. Najmul Hosen, Md. Saad Hossain, Md. Aftabur Rahman, Md. Sadman Hasan Sahil, Tanjuma Tasnim Hira, Ifthesum, Ashikur Rahaman, Md. Afser Rabbi, Laila Khaleda   +13 more
wiley   +1 more source

Image 2_Cannabis and cannabinoids in dermatology: a systematic review and meta-analysis of quantitative outcomes.jpeg

Pim Sermsaksasithorn (12912739), Tanawin Nopsopon (10515121), Chatpol Samuthpongtorn (14049186), Korn Chotirosniramit (9216546), Krit Pongpirul (5735576)   +4 more
openalex   +1 more source

No association of rs2501431 polymorphism of cannabinoid receptor 2 gene with bone mineral density in Chinese postmenopausal women

, 2012
Xilian Hu
openalex   +1 more source

Milk Fat Globule Membrane Supplementation Attenuates Cognitive Impairment in APP/PS1 Mice via Suppressing Neuroinflammation in a Gut Microbiota‐Mediated Serum Resolvin D1/Anandamide Manner

Food Frontiers, Volume 7, Issue 2, March 2026.
MFGM modulated gut microbiota accompanied by the increased serum RVD1 and AEA levels, which subsequently regulated the miRNA profile. This modulation alleviated neuroinflammation via suppressing the NLRP3 inflammasome signaling and microglial activation, thereby attenuating AD‐related cognitive impairment both in vivo and in vitro.
Han Gong, Qichen Yuan, Min Du, Xiaohan Liu, Xueying Mao   +4 more
wiley   +1 more source